Newsbot

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Actinium Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - ATNM

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Actinium Pharmaceuticals, Inc. (“Actinium” or the “Company”) (NYSE: ATNM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Solaris Energy Infrastructure, Inc. of Class Action Lawsuit and Upcoming Deadlines - SEI

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Solaris Energy Infrastructure, Inc. (“SEI” or the “Company”) (NYSE: SEI).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ibotta, Inc of Class Action Lawsuit and Upcoming Deadlines - IBTA

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ibotta, Inc. (“Ibotta” or the “Company”) (NYSE: IBTA).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Everus Construction Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - ECG

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Everus Construction Group, Inc. (“Everus” or the “Company”) (NYSE: ECG).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in UnitedHealth Group Incorporated of Class Action Lawsuit and Upcoming Deadlines - UNH

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against UnitedHealth Group Incorporated (“UnitedHealth” or the “Company”) (NYSE: UNH).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Napco Security Technologies, Inc. of Class Action Lawsuit and Upcoming Deadlines - NSSC

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Napco Security Technologies, Inc. (“Napco” or the “Company”) (NASDAQ: NSSC).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Open Lending Corporation of Class Action Lawsuit and Upcoming Deadlines - LPRO

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Open Lending Corporation. (“Open Lending” or the “Company”) (NASDAQ: LPRO).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Compass Diversified Holdings of Class Action Lawsuit and Upcoming Deadlines - CODI

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Compass Diversified Holdings (“CODI” or the “Company”) (NYSE: CODI).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Merz setzt Ukraine-Diplomatie im Petersdom fort

ROM (dpa-AFX) - Bundeskanzler Friedrich Merz hat am Rande der Amtseinführung des Papstes weitere Gespräche geführt, um die Bemühungen um ein Ende des Ukraine-Kriegs voranzutreiben. Im Petersdom sprach er mit dem ukrainischen Präsidenten Wolodymyr Sel...

Archer Aviation Stock Soars: Is It Still a Buy Below $13?

The bull market may be returning. Investors in Archer Aviation (NYSE: ACHR) certainly think so, with the stock shooting up close to 70% in the past month on the back of an optimistic earnings report. The upstart builder of electric air taxis is trying to disrupt the transportation market with its new Midnight aircraft and has orders from governments and corporations around the world. However, the company is still in the certification stage and is not generating any revenue at the moment. With th...

Analoges Abenteuer für digitale Ritter: Gamer erobern Trosky

Mittelalter trifft Game-Controller: Seit der Spiele-Hit "Kingdom Come: Deliverance II" Millionen Gamer begeistert, verzeichnet die Burgruine Trosky im Norden Tschechiens auffällig steigende Besucherzahlen. Von D. Handrick.

Ramit Sethi Explains How Automatic Investing Can Grow Your Wealth: If You Dont See It, You Wont Miss It

Ramit Sethi has helped millions of people improve their finances with his book, "I Will Teach You To Be Rich." Many of the strategies he shared in his book still hold value, including automatic investing. Sethi recently shared an X post that came in response to a question in an online forum. The question revolves around a piece of advice that sounded stupid at first but turned out to be life-changing. He used the opportunity to tout the benefits of automatically investing 10% of your income. "If

Nach Papst-Messe: Spontanes EU-USA-Spitzentreffen in Rom

ROM (dpa-AFX) - Nach der großen Messe von Papst Leo XIV. kommt es in Rom zu einem kurzfristigen EU-USA-Spitzentreffen. EU-Kommissionspräsidentin Ursula von der Leyen und US-Vizepräsident JD Vance werden am Sonntagnachmittag (15.30 Uhr) bei der italie...

Prediction: This Beaten-Down Stock Could Double in The Next 5 Years

Despite making significant clinical progress, CRISPR Therapeutics (NASDAQ: CRSP) has been struggling financially in the past three years. The companys shares are down by 24% over this period, while the S&P 500 has gained 41%. The gene-editing specialist has, no doubt, faced some headwinds. However, important catalysts could double its stock price by 2030. For those keeping score at home, that would amount to a compound annual growth rate of about 14.9%, well above the markets historical averag...

Erhöhung der Pendlerpauschale: NRW kündigt Widerstand an

DÜSSELDORF (dpa-AFX) - Nordrhein-Westfalen will ein Projekt der neuen Bundesregierung nur mittragen, falls es einen finanziellen Ausgleich gibt. NRW-Finanzminister Marcus Optendrenk (CDU) kündigte an, dass das Land die von CDU und SPD angekündigte Er...

IG Metall: Hanseyachts will 200 Arbeitsplätze abbauen

GREIFSWALD (dpa-AFX) - Der Jachtenbauer Hanseyachts plant nach Angaben der IG Metall an seinem Standort in Greifswald 200 Arbeitsplätze abzubauen. Wie die Gewerkschaft mitteilte, wurde der Betriebsrat bereits am 9. Mai vom Arbeitgeber aufgefordert, u...

Schwesig: Schwung für Wirtschaft wichtigstes Ziel

BAD SAAROW (dpa-AFX) - Mecklenburg-Vorpommerns Ministerpräsidentin Manuela Schwesig (SPD) sieht die neue Bundesregierung in der Pflicht, die Wirtschaft wieder in Schwung zu bringen. "Das dritte Jahr infolge kein Wirtschaftswachstum - das geht so nich...

Gesundheitsministerin plant Verbot von Lachgas als Partydroge

BERLIN (dpa-AFX) - Bundesgesundheitsministerin Nina Warken will als eine ihrer ersten Amtshandlungen ein Verbot von Lachgas als Partydroge auf den Weg bringen. "Lachgas ist kein harmloser Spaß, sondern insbesondere für Kinder und Jugendliche mit hohe...

Umfrage: Schwimmbadbesuch könnte teurer werden

BERLIN (dpa-AFX) - Ab ins Freibad! Erwachsene kommen mit Kindheitserinnerungen, Schülerinnen und Schüler mit Lust auf Pommes, Eis und Wasserrutsche: Vielerorts hat die Freibadsaison begonnen, auch wenn es zuletzt so manchem noch zu kalt gewesen sein ...

Iran widerspricht Trump: Noch kein US-Vorschlag im Atomstreit

TEHERAN (dpa-AFX) - Der iranische Außenminister Abbas Araghtschi hat der Darstellung von US-Präsident Donald Trump widersprochen, dass Teheran ein Vorschlag zur Beilegung des Atomstreits vorliege. Es gebe weder ein direktes noch ein indirektes Angebo...

Merz ruft zu Reformen der Sicherungssysteme auf

STUTTGART (dpa-AFX) - Die neue Bundesregierung muss aus Sicht von Kanzler Friedrich Merz (CDU) mehr voranbringen als im Koalitionsvertrag vereinbart. "Wir haben in den Koalitionsvertrag viele richtige Dinge aufgeschrieben", sagte Merz auf dem Parteit...

Experten: Fachkräftemangel gefährdet Aufschwung

Die Fachkräftelücke in Deutschland ist zwar kleiner geworden - Experten sehen in dem Mangel an qualifizierten Arbeitskräften aber weiterhin ein Hemmnis für die deutsche Wirtschaft. Laut Kompetenzzentrum Fachkräftesicherung (Kofa) blieb im März jede dritte offene Stelle unbesetzt - insgesamt gut 387.000. Das waren 17,5 Prozent weniger als vor einem Jahr. "Besonders gravierend ist der Fachkräftemang...

US Army Secretary Driscoll: We Are Doing the Right Thing

An update on a story we told in November about the state of the defense industry. US Army Secretary Daniel Driscoll tells us about the Trump administrations approach to the US army’s budget, including funding more defense tech start-ups. (Source: Bloomberg)

1 Beaten-Down, Trillion-Dollar Artificial Intelligence (AI) Stock to Buy on the Dip

Alphabets (NASDAQ: GOOG) (NASDAQ: GOOGL) shares are down by 12% this year, partly due to being swept up in broader market volatility. However, the company has faced issues of its own. The stock could remain volatile in the short run, and developments could disrupt the companys dominance in the search engine niche. Despite these challenges, Alphabet remains an excellent stock to buy while its shares are down -- and to hold on to for a while, even with a market capitalization of about $2 trillio...